Literature DB >> 22260159

Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm.

Lila Gilis, Laure Lebras, Fadhela Bouafia-Sauvy, Daniel Espinouse, Pascale Felman, Francoise Berger, Gilles Salles, Bertrand Coiffier, Anne-Sophie Michallet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22260159     DOI: 10.3109/10428194.2012.656627

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  7 in total

Review 1.  Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Daniel Kerr; Ling Zhang; Lubomir Sokol
Journal:  Curr Treat Options Oncol       Date:  2019-02-04

2.  How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Authors:  Francine Garnache-Ottou; Chrystelle Vidal; Sabeha Biichlé; Florian Renosi; Eve Poret; Maïder Pagadoy; Maxime Desmarets; Anne Roggy; Estelle Seilles; Lou Soret; Françoise Schillinger; Sandrine Puyraimond; Tony Petrella; Claude Preudhomme; Christophe Roumier; Elisabeth A MacIntyre; Véronique Harrivel; Yohan Desbrosses; Bérengère Gruson; Franck Geneviève; Sylvain Thepot; Yuriy Drebit; Thibaut Leguay; François-Xavier Gros; Nicolas Lechevalier; Pascale Saussoy; Véronique Salaun; Edouard Cornet; Zehaira Benseddik; Richard Veyrat-Masson; Orianne Wagner-Ballon; Célia Salanoubat; Marc Maynadié; Julien Guy; Denis Caillot; Marie-Christine Jacob; Jean-Yves Cahn; Rémy Gressin; Johann Rose; Bruno Quesnel; Estelle Guerin; Franck Trimoreau; Jean Feuillard; Marie-Pierre Gourin; Adriana Plesa; Lucile Baseggio; Isabelle Arnoux; Norbert Vey; Didier Blaise; Romaric Lacroix; Christine Arnoulet; Blandine Benet; Véronique Dorvaux; Caroline Bret; Bernard Drenou; Agathe Debliquis; Véronique Latger-Cannard; Caroline Bonmati; Marie-Christine Bene; Pierre Peterlin; Michel Ticchioni; Pierre-Simon Rohrlich; Anne Arnaud; Stefan Wickenhauser; Valérie Bardet; Sabine Brechignac; Benjamin Papoular; Victoria Raggueneau; Jacques Vargaftig; Rémi Letestu; Daniel Lusina; Thorsten Braun; Vincent Foissaud; Jérôme Tamburini; Hind Bennani; Nicolas Freynet; Catherine Cordonnier; Magali Le Garff-Tavernier; Nathalie Jacques; Karim Maloum; Damien Roos-Weil; Didier Bouscary; Vahid Asnafi; Ludovic Lhermitte; Felipe Suarez; Etienne Lengline; Frédéric Féger; Giorgia Battipaglia; Mohamad Mohty; Sabrina Bouyer; Ouda Ghoual; Elodie Dindinaud; Caroline Basle; Mathieu Puyade; Carinne Lafon; Thierry Fest; Mikael Roussel; Xavier Cahu; Elsa Bera; Sylvie Daliphard; Fabrice Jardin; Lydia Campos; Françoise Solly; Denis Guyotat; Anne-Cécile Galoisy; Alice Eischen; Caroline Mayeur-Rousse; Blandine Guffroy; Christian Recher; Marie Loosveld; Alice Garnier; Vincent Barlogis; Maria Alessandra Rosenthal; Sophie Brun; Nathalie Contentin; Sébastien Maury; Mary Callanan; Christine Lefebvre; Natacha Maillard; Patricia Okamba; Christophe Ferrand; Olivier Adotevi; Philippe Saas; Fanny Angelot-Delettre; Delphine Binda; Eric Deconinck
Journal:  Blood Adv       Date:  2019-12-23

3.  In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.

Authors:  Fanny Angelot-Delettre; Anne Roggy; Arthur E Frankel; Baptiste Lamarthee; Estelle Seilles; Sabeha Biichle; Bernard Royer; Eric Deconinck; Eric K Rowinsky; Christopher Brooks; Valerie Bardet; Blandine Benet; Hind Bennani; Zehaira Benseddik; Agathe Debliquis; Daniel Lusina; Mikael Roussel; Françoise Solly; Michel Ticchioni; Philippe Saas; Francine Garnache-Ottou
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

4.  BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicity.

Authors:  Margaux Poussard; Laure Philippe; Maxime Fredon; Elodie Bôle-Richard; Sabeha Biichle; Florian Renosi; Sophie Perrin; Marie Kroemer; Samuel Limat; Francis Bonnefoy; Etienne Daguindau; Eric Deconinck; Bérengère Gruson; Philippe Saas; Olivier Adotévi; Francine Garnache-Ottou; Fanny Angelot-Delettre
Journal:  EJHaem       Date:  2020-12-13

5.  Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients.

Authors:  Kamel Laribi; Alix Baugier de Materre; Mohamad Sobh; Lorenzo Cerroni; Caterina Giovanna Valentini; Tomohiro Aoki; Ritsuro Suzuki; Kengo Takeuchi; Arthur E Frankel; Carlo Cota; David Ghez; Ronan Le Calloch; Livio Pagano; Tony Petrella
Journal:  Blood Adv       Date:  2020-10-13

6.  Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm.

Authors:  Laure Philippe; Adam Ceroi; Elodie Bôle-Richard; Alizée Jenvrin; Sabeha Biichle; Sophie Perrin; Samuel Limat; Francis Bonnefoy; Eric Deconinck; Philippe Saas; Francine Garnache-Ottou; Fanny Angelot-Delettre
Journal:  Haematologica       Date:  2017-08-10       Impact factor: 9.941

Review 7.  Conventional Therapeutics in BPDCN Patients-Do They Still Have a Place in the Era of Targeted Therapies?

Authors:  Margaux Poussard; Fanny Angelot-Delettre; Eric Deconinck
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.